DISCOVER INGESTEM

INGESTEM : STEM CELLS FOR TISSUE ENGINEERING

INGESTEM, a National Infrastructure in Biology and Health certified by the "Plan Investissement d'Avenir" program (2012-2019), is the first French consortium of therapeutic innovations based on induced pluripotent stem cells (iPS cells) and human tissue engineering . Our ambition is to use the major potential of cellular reprogramming techniques to generate models of human diseases and regenerative medicine.

READ MORE

WORK TOGETHER

INGESTEM is a research and development platform open to external users.

INGESTEM is open to academic, industrial and clinical research. It develops technologies on embryonic stem cells and iPS cells to discover and validate new therapeutic concepts. Academic and industrial R&D collaborations with the INGESTEM teams are avalaible, as well as on demand services and training.

READ MORE